Pharmaceutical marketing code of ethics

is aimed at ensuring the transparency and compliance of the activities of pharmaceutical companies operating in Lithuania with the principles of professional ethics.

The Code of Ethics for Pharmaceutical Marketing has been adopted at the will and upon common agreement of IFPA and VGA – associations of companies engaged in pharmaceutical marketing in Lithuania.

Pharmaceutical marketing code of ethics

Has been adopted

at the will and upon common agreement of IFPA and VGA.

Code seeks to

ensure that pharmaceutical companies engage in an ethical promotion, restrain from deceitful practices and potential conflicts of interest with healthcare professionals, and comply with applicable laws and regulations.

It is applied

to companies engaged in pharmaceutical marketing in Lithuania.

Thus the Code seeks to enable an environment where the general public may be sure that the choices regarding their medicinal products are made based on the merit of each product and the patients’ clinical needs. This Code does not aim at restraining the promotion of medicines in such a way as to hinder fair competition or limit interaction with healthcare professionals. Guided by the mission of EFPIA and common goals with IFPA and VGA, other parties, not belonging to IFPA and VGA, can also join the Code.